Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • New Delhi

    Tag: new delhi

    You Searched For "New Delhi"
    Cadila Healthcare posts Q4 net profit of Rs 460 crore

    Cadila Healthcare posts Q4 net profit of Rs 460 crore

    Medical Dialogues Bureau30 May 2019 9:15 AM IST
    The consolidated financial statements for the quarter and the year ended March 31, 2019, including the operations of Heinz India Pvt Ltd (HIPL) for...
    Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules

    Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules

    Farhat Nasim28 May 2019 10:00 AM IST
    The approved product, Methylphenidate Hydrochloride extended-release capsules, is bioequivalent to the reference listed drug product (RLD), Ritalin LA...
    Natco Pharma Q4 PAT plunges to Rs 120 crore

    Natco Pharma Q4 PAT plunges to Rs 120 crore

    Garima28 May 2019 9:45 AM IST
    The company's board has declared a third interim dividend of Rs 1.25 per equity share of Rs 2 each, resulting in a total dividend payout of Rs 6.25...
    Cipla plans to file over dozen new drug applications for FY20

    Cipla plans to file over dozen new drug applications for FY20

    Garima27 May 2019 9:30 AM IST
    In another key market of South Africa, during the current fiscal year, Cipla is looking to strengthen its OTC (over-the-counter) business.New Delhi:...
    GSK, Pfizer gets CCI approval for consumer healthcare JV formation

    GSK, Pfizer gets CCI approval for consumer healthcare JV formation

    Garima25 May 2019 9:45 AM IST
    After the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business, while Pfizer will...
    Cipla gets no USFDA observations for Indore facility

    Cipla gets no USFDA observations for Indore facility

    Farhat Nasim18 May 2019 9:45 AM IST
    The US health regulator conducted a post-approval inspection at Cipla Ltd's Indore facility from 13th May to 17th May 2019. New Delhi: Drug firm Cipla...
    Zydus Cadila gets USFDA nod for Chlorthalidone tablets to treat high BP

    Zydus Cadila gets USFDA nod for Chlorthalidone tablets to treat high BP

    Farhat Nasim13 May 2019 10:31 AM IST
    Zydus Cadila said Chlorthalidone tablets will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.New Delhi: Drug...
    Biocon commercial rights on biosimilar adalimumab extends to global markets

    Biocon commercial rights on biosimilar adalimumab extends to global markets

    Farhat Nasim8 May 2019 9:45 AM IST
    Biocon, under the terms of its global partnership with Mylan for monoclonal antibodies, retains its economic interest in this expanded in-licensing...
    Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences

    Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences

    Medical Dialogues Bureau8 May 2019 9:15 AM IST
    Yasir Rawjee joins Glenmark Life Sciences from Mylan, where most recently he was the Head of Global API Operations, Glenmark Pharmaceuticals said in a...
    Union Health Minister asked not to receive donations from JnJ for TB Control Program

    Union Health Minister asked not to receive donations from JnJ for TB Control Program

    Medical Dialogues Bureau3 May 2019 9:15 AM IST
    Recently, Johnson & Johnson (JnJ) had announced to provide an additional 10,000 courses of tuberculosis drug bedaquiline (BDQ) to the Indian...
    Zydus Cadila gets USFDA nod to market 2 generic drugs

    Zydus Cadila gets USFDA nod to market 2 generic drugs

    Medical Dialogues Bureau1 May 2019 8:05 PM IST
    New Delhi: Drug firm Zydus Cadila Tuesday said it has received the final nod from the USFDA to market generic Bosentan tablets and Trientine...
    Using AI to detect mental health disorders likely to be counterproductive

    Using AI to detect mental health disorders likely to be counterproductive

    Medical Dialogues Bureau30 April 2019 9:00 AM IST
    AI-based vocal analytics may allow patients to detect the disease at home by just speaking into a smartphone application, eliminating the need to be...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok